ArticleInternational journal of clinical oncology2024

EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system.

Kotaro Nomura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.